$CAH
CARDINAL HEALTH INC

2023 Q2 Form 10-Q Financial Statement

#000162828023015775 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $53.45B $50.49B
YoY Change 13.48% 12.6%
Cost Of Revenue $51.63B $48.70B
YoY Change 13.47% 12.86%
Gross Profit $1.827B $1.785B
YoY Change 13.83% 6.12%
Gross Profit Margin 3.42% 3.54%
Selling, General & Admin $1.267B $1.179B
YoY Change 9.7% 3.69%
% of Gross Profit 69.35% 66.05%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $176.0M $175.0M
YoY Change -1.68% -3.31%
% of Gross Profit 9.63% 9.8%
Operating Expenses $1.337B $1.179B
YoY Change 8.61% 3.69%
Operating Profit $490.0M $572.0M
YoY Change 31.02% -689.69%
Interest Expense -$15.00M $28.00M
YoY Change -55.88% -26.32%
% of Operating Profit -3.06% 4.9%
Other Income/Expense, Net -$1.000M $0.00
YoY Change -96.67% -100.0%
Pretax Income $121.0M $544.0M
YoY Change -532.14% -497.08%
Income Tax $187.0M $197.0M
% Of Pretax Income 154.55% 36.21%
Net Earnings -$64.00M $345.0M
YoY Change -146.38% -124.8%
Net Earnings / Revenue -0.12% 0.68%
Basic Earnings Per Share $1.43
Diluted Earnings Per Share -$0.25 $1.34
COMMON SHARES
Basic Shares Outstanding 254.6M shares 257.6M shares
Diluted Shares Outstanding 258.0M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.043B $3.990B
YoY Change -14.29% 69.35%
Cash & Equivalents $4.043B $3.990B
Short-Term Investments
Other Short-Term Assets $2.362B $1.895B
YoY Change 16.87% -31.96%
Inventory $15.94B $16.62B
Prepaid Expenses
Receivables $11.34B $10.99B
Other Receivables $0.00 $0.00
Total Short-Term Assets $33.83B $33.50B
YoY Change 2.73% 8.46%
LONG-TERM ASSETS
Property, Plant & Equipment $2.462B $2.362B
YoY Change 4.28% 2.79%
Goodwill $4.609B $5.000B
YoY Change -21.28% -18.92%
Intangibles $1.472B $1.567B
YoY Change -17.02% -15.53%
Long-Term Investments
YoY Change
Other Assets $1.041B $951.0M
YoY Change 9.23% 4.85%
Total Long-Term Assets $9.584B $9.880B
YoY Change -12.42% -12.0%
TOTAL ASSETS
Total Short-Term Assets $33.83B $33.50B
Total Long-Term Assets $9.584B $9.880B
Total Assets $43.42B $43.38B
YoY Change -1.05% 3.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $29.81B $29.60B
YoY Change 9.9% 19.26%
Accrued Expenses $3.059B $2.876B
YoY Change 7.64% -5.18%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $792.0M $26.00M
YoY Change 36.55% -96.98%
Total Short-Term Liabilities $33.71B $32.50B
YoY Change 10.33% 13.19%
LONG-TERM LIABILITIES
Long-Term Debt $3.909B $4.708B
YoY Change -17.44% -0.91%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $3.909B $4.708B
YoY Change -17.44% -0.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $33.71B $32.50B
Total Long-Term Liabilities $3.909B $4.708B
Total Liabilities $46.27B $45.60B
YoY Change 3.77% 6.52%
SHAREHOLDERS EQUITY
Retained Earnings -$534.0M -$342.0M
YoY Change 90.71% 21.71%
Common Stock $2.747B $2.818B
YoY Change -2.35% 2.06%
Preferred Stock
YoY Change
Treasury Stock (at cost) $4.914B $4.554B
YoY Change 57.1% 46.9%
Treasury Stock Shares
Shareholders Equity -$2.852B -$2.220B
YoY Change
Total Liabilities & Shareholders Equity $43.42B $43.38B
YoY Change -1.05% 3.01%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$64.00M $345.0M
YoY Change -146.38% -124.8%
Depreciation, Depletion And Amortization $176.0M $175.0M
YoY Change -1.68% -3.31%
Cash From Operating Activities $858.0M $1.361B
YoY Change -71.32% -424.82%
INVESTING ACTIVITIES
Capital Expenditures $217.0M $109.0M
YoY Change -232.32% -232.93%
Acquisitions
YoY Change
Other Investing Activities $11.00M $18.00M
YoY Change -127.5% -52.63%
Cash From Investing Activities -$206.0M -$91.00M
YoY Change 0.98% 106.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -592.0M -934.0M
YoY Change 42.65% 174.71%
NET CHANGE
Cash From Operating Activities 858.0M 1.361B
Cash From Investing Activities -206.0M -91.00M
Cash From Financing Activities -592.0M -934.0M
Net Change In Cash 60.00M 336.0M
YoY Change -97.47% -141.84%
FREE CASH FLOW
Cash From Operating Activities $858.0M $1.361B
Capital Expenditures $217.0M $109.0M
Free Cash Flow $641.0M $1.252B
YoY Change -79.69% -471.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000721371
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-11373
dei Entity Registrant Name
EntityRegistrantName
Cardinal Health, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
OH
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
31-0958666
dei Entity Address Address Line1
EntityAddressAddressLine1
7000 Cardinal Place
dei Entity Address City Or Town
EntityAddressCityOrTown
Dublin
dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
43017
dei City Area Code
CityAreaCode
614
dei Local Phone Number
LocalPhoneNumber
757-5000
dei Security12b Title
Security12bTitle
Common shares (without par value)
dei Trading Symbol
TradingSymbol
CAH
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
254600182 shares
CY2023Q1 us-gaap Revenues
Revenues
50487000000 usd
CY2022Q1 us-gaap Revenues
Revenues
44836000000 usd
us-gaap Revenues
Revenues
151559000000 usd
us-gaap Revenues
Revenues
134261000000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
48702000000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
43154000000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
146497000000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
129321000000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
1785000000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
1682000000 usd
us-gaap Gross Profit
GrossProfit
5062000000 usd
us-gaap Gross Profit
GrossProfit
4940000000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1179000000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1137000000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3567000000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3402000000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
16000000 usd
CY2022Q1 us-gaap Restructuring Charges
RestructuringCharges
31000000 usd
us-gaap Restructuring Charges
RestructuringCharges
62000000 usd
us-gaap Restructuring Charges
RestructuringCharges
56000000 usd
CY2023Q1 cah Amortizationandotheracquisitionrelatedcosts
Amortizationandotheracquisitionrelatedcosts
74000000 usd
CY2022Q1 cah Amortizationandotheracquisitionrelatedcosts
Amortizationandotheracquisitionrelatedcosts
79000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14000000 usd
cah Amortizationandotheracquisitionrelatedcosts
Amortizationandotheracquisitionrelatedcosts
216000000 usd
cah Amortizationandotheracquisitionrelatedcosts
Amortizationandotheracquisitionrelatedcosts
237000000 usd
CY2023Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-20000000 usd
CY2022Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-471000000 usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-883000000 usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-1764000000 usd
CY2023Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
76000000 usd
CY2022Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-61000000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
256000000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-113000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
572000000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-97000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
590000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-632000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
28000000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
38000000 usd
us-gaap Interest Expense
InterestExpense
78000000 usd
us-gaap Interest Expense
InterestExpense
115000000 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10000000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 usd
CY2022Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
1000000 usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
2000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
544000000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-137000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
517000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-741000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
197000000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1253000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
189000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
328000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
347000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1390000000 usd
us-gaap Profit Loss
ProfitLoss
328000000 usd
us-gaap Profit Loss
ProfitLoss
-1069000000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2000000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
345000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1391000000 usd
us-gaap Net Income Loss
NetIncomeLoss
325000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1071000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.35
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-5.05
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.24
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-3.82
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.34
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-5.05
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.23
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-3.82
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
256000000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
275000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
263000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
281000000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
258000000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
275000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
264000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
281000000 shares
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.4957
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.4908
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.4871
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.4724
CY2023Q1 us-gaap Profit Loss
ProfitLoss
347000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1390000000 usd
us-gaap Profit Loss
ProfitLoss
328000000 usd
us-gaap Profit Loss
ProfitLoss
-1069000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
4000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4000000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-34000000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-47000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
12000000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
6000000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
4000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-28000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-43000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
351000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1382000000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
300000000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1112000000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2000000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
349000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1383000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
297000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1114000000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3990000000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4717000000 usd
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
10992000000 usd
CY2022Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
10561000000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
16620000000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
15636000000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1895000000 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
2021000000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
33497000000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
32935000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2362000000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2361000000 usd
CY2023Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
6567000000 usd
CY2022Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
7629000000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
951000000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
953000000 usd
CY2023Q1 us-gaap Assets
Assets
43377000000 usd
CY2022Q2 us-gaap Assets
Assets
43878000000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
29601000000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
27128000000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
26000000 usd
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
580000000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2876000000 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2842000000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
32503000000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
30550000000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
4708000000 usd
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
4735000000 usd
CY2023Q1 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
8384000000 usd
CY2022Q2 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
9299000000 usd
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
755000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
755000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
327000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
327000000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
2818000000 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
2813000000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-342000000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-280000000 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
72000000 shares
CY2022Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
54000000 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
4554000000 usd
CY2022Q2 us-gaap Treasury Stock Value
TreasuryStockValue
3128000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-142000000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-114000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-2220000000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-709000000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
2000000 usd
CY2022Q2 us-gaap Minority Interest
MinorityInterest
3000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2218000000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-706000000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43377000000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43878000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2212000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
345000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
347000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4000000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
24000000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
253000000 usd
CY2023Q1 us-gaap Dividends
Dividends
128000000 usd
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
0 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2218000000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1002000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1391000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1390000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
8000000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
23000000 usd
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
200000000 usd
CY2022Q1 us-gaap Dividends
Dividends
135000000 usd
CY2022Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-1000000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-693000000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-706000000 usd
us-gaap Net Income Loss
NetIncomeLoss
325000000 usd
us-gaap Profit Loss
ProfitLoss
328000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-28000000 usd
us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
-2000000 usd
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
2000000 shares
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
82000000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1503000000 usd
us-gaap Dividends
Dividends
388000000 usd
us-gaap Stockholders Equity Other
StockholdersEquityOther
-1000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2218000000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1794000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1071000000 usd
us-gaap Profit Loss
ProfitLoss
-1069000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-43000000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
41000000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1000000000 usd
us-gaap Dividends
Dividends
415000000 usd
us-gaap Stockholders Equity Other
StockholdersEquityOther
-1000000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-693000000 usd
us-gaap Profit Loss
ProfitLoss
328000000 usd
us-gaap Profit Loss
ProfitLoss
-1069000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
516000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
513000000 usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-883000000 usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-1764000000 usd
us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
0 usd
us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
-3000000 usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
2000000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
69000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
65000000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
79000000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
46000000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
510000000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1193000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1012000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
922000000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2473000000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1121000000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
845000000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
206000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1981000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
130000000 usd
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 usd
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
923000000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
10000000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
264000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
223000000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2000000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
11000000 usd
cah Purchaseofavailableforsalesecuritiesandotherinvestments
Purchaseofavailableforsalesecuritiesandotherinvestments
6000000 usd
cah Purchaseofavailableforsalesecuritiesandotherinvestments
Purchaseofavailableforsalesecuritiesandotherinvestments
38000000 usd
cah Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
1000000 usd
cah Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
27000000 usd
us-gaap Proceeds From Hedge Investing Activities
ProceedsFromHedgeInvestingActivities
29000000 usd
us-gaap Proceeds From Hedge Investing Activities
ProceedsFromHedgeInvestingActivities
71000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-248000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
771000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
571000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
597000000 usd
cah Netproceedstaxwithholdingsfromsharebasedcompensation
Netproceedstaxwithholdingsfromsharebasedcompensation
11000000 usd
cah Netproceedstaxwithholdingsfromsharebasedcompensation
Netproceedstaxwithholdingsfromsharebasedcompensation
-26000000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
399000000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
425000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1500000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1000000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2459000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2048000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-13000000 usd
cah Cash Reclassified To Asset Held For Sale
CashReclassifiedToAssetHeldForSale
0 usd
cah Cash Reclassified To Asset Held For Sale
CashReclassifiedToAssetHeldForSale
109000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-727000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1051000000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4717000000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3407000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3990000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2356000000 usd
CY2023Q1 us-gaap Severance Costs1
SeveranceCosts1
3000000 usd
CY2022Q1 us-gaap Severance Costs1
SeveranceCosts1
12000000 usd
CY2023Q1 cah Facility Exit And Other Costs
FacilityExitAndOtherCosts
13000000 usd
CY2022Q1 cah Facility Exit And Other Costs
FacilityExitAndOtherCosts
19000000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
16000000 usd
CY2022Q1 us-gaap Restructuring Charges
RestructuringCharges
31000000 usd
us-gaap Severance Costs1
SeveranceCosts1
32000000 usd
us-gaap Severance Costs1
SeveranceCosts1
22000000 usd
cah Facility Exit And Other Costs
FacilityExitAndOtherCosts
30000000 usd
cah Facility Exit And Other Costs
FacilityExitAndOtherCosts
34000000 usd
us-gaap Restructuring Charges
RestructuringCharges
62000000 usd
us-gaap Restructuring Charges
RestructuringCharges
56000000 usd
CY2022Q2 us-gaap Restructuring Reserve
RestructuringReserve
66000000 usd
us-gaap Restructuring Costs
RestructuringCosts
37000000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
51000000 usd
CY2023Q1 us-gaap Restructuring Reserve
RestructuringReserve
52000000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
5855000000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
13000000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-5000000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
863000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
5000000000 usd
CY2023Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
11000000 usd
CY2023Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
11000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4822000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3266000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1556000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P10Y
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
236000000 usd
CY2023Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
4833000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3266000000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1567000000 usd
CY2022Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
11000000 usd
CY2022Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
11000000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4862000000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3099000000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1763000000 usd
CY2022Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
4873000000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3099000000 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1774000000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
69000000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
78000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
211000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
235000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
71000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
261000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
209000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
177000000 usd
CY2023Q1 cah Total Long Termand Short Term Obligations
TotalLongTermandShortTermObligations
4700000000 usd
CY2022Q2 cah Total Long Termand Short Term Obligations
TotalLongTermandShortTermObligations
5300000000 usd
CY2023Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
29600000000 usd
CY2022Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
27100000000 usd
us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
4000000 usd
cah Incomefrom Settlementsof Class Action Lawsuits
IncomefromSettlementsofClassActionLawsuits
66000000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.363
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.367
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-9.165
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.444
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1100000000 usd
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
943000000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
897000000 usd
CY2022Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
858000000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
61000000 usd
CY2022Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
48000000 usd
us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
0 usd
us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
0 usd
CY2022Q1 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
0 usd
CY2023Q1 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
0 usd
CY2023Q1 cah Carrying Amountof Long Termandother Short Term Borrowings
CarryingAmountofLongTermandotherShortTermBorrowings
4734000000 usd
CY2022Q2 cah Carrying Amountof Long Termandother Short Term Borrowings
CarryingAmountofLongTermandotherShortTermBorrowings
5315000000 usd
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
5000000 usd
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
6000000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
256000000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
275000000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2000000 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
258000000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
275000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
263000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
281000000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1000000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
264000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
281000000 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2000000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5000000 shares
CY2022Q1 cah Shares That Would Be Antidilutive As A Result Of Net Loss
SharesThatWouldBeAntidilutiveAsAResultOfNetLoss
2000000 reportable_segments
cah Shares That Would Be Antidilutive As A Result Of Net Loss
SharesThatWouldBeAntidilutiveAsAResultOfNetLoss
1000000 reportable_segments
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023Q1 us-gaap Revenues
Revenues
50487000000 usd
CY2022Q1 us-gaap Revenues
Revenues
44836000000 usd
us-gaap Revenues
Revenues
151559000000 usd
us-gaap Revenues
Revenues
134261000000 usd
CY2023Q1 us-gaap Revenues
Revenues
50487000000 usd
CY2022Q1 us-gaap Revenues
Revenues
44836000000 usd
us-gaap Revenues
Revenues
151559000000 usd
us-gaap Revenues
Revenues
134261000000 usd
CY2023Q1 cah Project Costs On Investment And Other Spending
ProjectCostsOnInvestmentAndOtherSpending
9000000 usd
CY2022Q1 cah Project Costs On Investment And Other Spending
ProjectCostsOnInvestmentAndOtherSpending
20000000 usd
cah Project Costs On Investment And Other Spending
ProjectCostsOnInvestmentAndOtherSpending
20000000 usd
cah Project Costs On Investment And Other Spending
ProjectCostsOnInvestmentAndOtherSpending
38000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
572000000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-97000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
590000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-632000000 usd
CY2022Q1 cah Contingent Attorney Fee
ContingentAttorneyFee
18000000 usd
cah Contingent Attorney Fee
ContingentAttorneyFee
18000000 usd
CY2023Q1 us-gaap Assets
Assets
43377000000 usd
CY2022Q2 us-gaap Assets
Assets
43878000000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21000000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23000000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
69000000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
65000000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3000000 usd
CY2022Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3000000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
9000000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
9000000 usd

Files In Submission

Name View Source Status
cah-20230331_lab.xml Edgar Link unprocessable
0001628280-23-015775-index-headers.html Edgar Link pending
0001628280-23-015775-index.html Edgar Link pending
0001628280-23-015775.txt Edgar Link pending
0001628280-23-015775-xbrl.zip Edgar Link pending
a23q3_10qx33123xexhibit311.htm Edgar Link pending
a23q3_10qx33123xexhibit312.htm Edgar Link pending
a23q3_10qx33123xexhibit321.htm Edgar Link pending
a23q3_10qx33123xexhibit991.htm Edgar Link pending
cah-20230331.htm Edgar Link pending
cah-20230331.xsd Edgar Link pending
cah-20230331_cal.xml Edgar Link unprocessable
cah-20230331_g1.jpg Edgar Link pending
cah-20230331_g2.jpg Edgar Link pending
cah-20230331_g3.jpg Edgar Link pending
cah-20230331_g4.jpg Edgar Link pending
cah-20230331_g5.jpg Edgar Link pending
cah-20230331_g6.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
cah-20230331_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cah-20230331_pre.xml Edgar Link unprocessable
cah-20230331_htm.xml Edgar Link completed
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending